Web Analytics




Home Tags Posts tagged with "China Pharma Regulations"

Tag: China Pharma Regulations

Pharma IPO Income Indicators and Risks
Practitioners' perspectives

Income indicators and risks for pharma IPOs

By Zhang Nan, W&H Law Firm

How income indicators and sales expenses impact risks in pharmaceutical IPOs under regulatory scrutiny

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Rajasthan Royals Acquisition Deal

Firms deliver IPL’s Rajasthan Royals to Indian consortium

India AI Digital Regulation Framework

Nurturing digital adoption with light-touch regulation

By Probir Roy Chowdhury and Sajai Singh, JSA
Candey Singapore Expansion APAC

Disputes boutique CANDEY opens in Singapore, eyes region

Auditor changes under HKEX’s new FAQ

Tighter scrutiny of auditor changes under HKEX’s new FAQ

By Stella Yeung and Stephen Luo, Jingtian & Gongcheng

Don’t judge land by its title: Lessons from spouses Manalese v Ferreras

By Nilo T Divina, Ciselie Marie T Gamo-Sisayan and Angel Isah M Romero, DivinaLaw
Elodie Dulac Joins Peter & Kim Singapore

Peter & Kim adds Singapore partner from King & Spalding

Correspondents

Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Arbitration Due Process Limitsvideo

Policy, process and delay in arbitral challenges

By Sneha Jaisingh and Jaidhara Shah, Bharucha & Partners
Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now